Thailand genomic surveillance for rapid response to emerging infections
Official title: RFA-GH-23-003, THAI-GER: THAIland Genomic surveillance of Emerging infectious diseases facilitating Rapid response
Funded at Mahidol University · NIH-11162236 · Data updated 2026-11-12
This project builds fast, easy genetic tests and data systems to find new infections and antibiotic-resistant germs quickly for people seen at hospitals and clinics in Thailand.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mahidol University NIH-funded |
| Lab location | 1 site (Nakhon Pathom, Thailand) |
| Project start | September 30, 2023 |
| Project end | September 29, 2028 |
| Funding year | 2025 |
| Award (this year) | $250,000 |
| NIH project number | 5U01GH002401-03 |
| Project ID | NIH-11162236 on NIH RePORTER |
Who could benefit from this research
✓Could help
People in Thailand who seek care for suspected infections at participating community, regional, or public-health hospitals and who can provide clinical samples would be the ideal participants.
✕Less likely to help
People outside the participating regions, those without access to participating hospitals, or patients with non-infectious conditions are unlikely to receive direct benefit from this project.
What this research studies
From a patient point of view, the team will work with community hospitals and public-health labs to collect clinical samples and install simple, field-friendly genetic tests and sequencing tools. They will create bioinformatics pipelines and a shared microbial genome database so results can be analyzed and shared quickly between local and central labs. Lab staff will receive training and improved lab-management systems to speed up testing during outbreaks. The goal is to make detecting new infections and antibiotic resistance faster and routine at local clinics.
Why it matters
Potential benefit: If successful, patients could get faster, more accurate diagnoses and earlier, better-targeted treatment while outbreaks are detected and controlled sooner.
How similar studies have gone: Genomic surveillance efforts during COVID-19 and for drug-resistant infections have successfully identified outbreaks and resistance patterns, so this project applies proven approaches to strengthen local capacity in Thailand.
Where this research is happening
-
Mahidol University
Nakhon Pathom, Thailand Active
Researchers
- Principal investigator: Horthongkham, Navin — Mahidol University
- Study coordinator: Horthongkham, Navin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.